HighMark Wealth Management »

Neuropace shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $650k 63k 10.31
2025-06-30 $702k 63k 11.14
2025-03-31 $37k 3.0k 12.29
2024-12-31 $34k 3.0k 11.19
2024-09-30 $21k 3.0k 6.97

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
OrbiMed Advisors
Morgan Stanley
BlackRock
Vanguard Group
First Light Asset Management
Armistice Capital
Kent Lake PR
Driehaus Capital Management
Deutsche Bank Aktiengesellschaft
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group

View all funds holding Neuropace